Blog
The Lymphflowcleanse blog
Three longer pieces, written because a product page has to stay on the product and these questions do not. One is about documents, one is about names, and one is about a piece of glass.
The Lymphflowcleanse blog covers the three questions this desk was asked most while reading this product: why the same figure means different things on a panel and in an advertisement, how a botanical ingredient is identified and which missing word decides a safety question, and why a serving size given in droppers cannot be turned into a dose.
The three posts
Read in that order, though none depends on the others. The first establishes why one number on this product supports less than it appears to. The second is about identity rather than quantity, and contains the most important thing on this site. The third is about the measurement that decides both the dose and how long a bottle lasts. All three were written from a product with no Supplement Facts panel at all — which is itself the argument for reading labels closely.
What each one covers
Where a number is printed changes what it means
Start here. A quantity on a Supplement Facts panel inherits three things from the structure around it: the serving is declared, a blend’s total is declared, and its ingredients are listed “in descending order of predominance by weight” — which is what converts an undisclosed blend into a set of hard ceilings. The post sets out four questions to ask about any printed figure, then runs them on this product’s only quantity: 600 mg of blend a serving, in a marketing graphic, with an undefined denominator, in a sentence that stops mid-clause.
Three words that decide a safety question
A botanical is identified by four things: the species, the plant part, the preparation and the standardisation. The post works through each column, shows with four worked examples that the plant part matters trivially on some rows and enormously on others, and then reaches horse chestnut — where the difference between a preparation NCCIH calls unsafe when used orally and one it calls likely safe is contained in three words this product does not print. It is careful throughout about what a blank column does and does not license anybody to say.
A dropper is not a unit
On liquid supplements generally. What a pipette actually delivers and why it varies; the four calculations a serving size in millilitres makes possible — the dose, the servings per bottle, the cost per serving and whether a bottle finishes inside a return window; and the concentration that falls out of the arithmetic. Then this bottle: 59 mL, two droppers a day, somewhere between 30 and 49 servings, and a 60-day window that runs from purchase.
How these posts are written
Every quotation comes from a source we opened
Ten documents: four from the FDA, five from NCCIH and one from the National Cancer Institute. They are listed at the foot of this page. If we could not open it, it is not quoted.
No invented studies, and no invented people
No reference this desk did not read, no “a 2019 study found” without the source, and no doctors, reviewers, customers or laboratory staff anywhere on this site.
No amount is ever stated for a blend ingredient
Only ceilings, and on this product only conditional ceilings. “At most 200 mg, if the printed order is the weight order” is a statement about a document; “200 mg” would be a fabrication, and that difference is the whole of the method.
Marketing is identified as marketing
The six ingredient names and the 600 mg figure both come from a sales graphic rather than from a label. Every page that uses them says so.
Where the sources are silent, we are silent
Gotu kola and quercetin return no monograph at either body this desk reads. The posts say so and stop, rather than substituting a related page that would read as evidence.
Why read a seller’s blog sceptically
Including this one. Most supplement blogs exist to occupy search results for the questions buyers ask on the way to a purchase, and the pieces are written backwards from the conclusion the seller wanted to reach.
So here is the test to apply to any of them, this blog included. Does a post ever reach a conclusion that costs the seller money? Do its sources open, and do they contain the sentences attached to them? Does it name a specific weakness in the product being sold? And does it say we do not know where the honest answer is that nobody does?
On this blog the answers are on the page. The first post concludes that this product’s only quantity supports no arithmetic about any individual ingredient. The second concludes that the single distinction a public health body draws on one of its ingredients cannot be checked. The third concludes that neither the dose nor the number of servings in a bottle can be worked out at all.
This site scores the product at 1.5 out of 5, recommends the single bottle rather than the largest pack, and publishes no rating, no review count and no testimonials.
The ten sources
Ten documents, all opened and read, all linked wherever they are quoted: four from the FDA, five from NCCIH, one from the National Cancer Institute. None of these bodies sells supplements, and all publish their uncertainty in the same sentences as their findings — which is what makes them quotable. A source that never says we do not know is not being careful.
- U.S. Food and Drug Administration (2026). Dietary Supplement Labeling Guide: Chapter I. General Dietary Supplement Labeling.
- U.S. Food and Drug Administration (2026). Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling.
- National Center for Complementary and Integrative Health (2025). Horse Chestnut: Usefulness and Safety.
- National Center for Complementary and Integrative Health (2025). Boswellia: Usefulness and Safety.
- National Center for Complementary and Integrative Health (2025). Turmeric: Usefulness and Safety.
- National Center for Complementary and Integrative Health (2025). Ginger: Usefulness and Safety.
- National Center for Complementary and Integrative Health (2026). Herbs at a Glance: A-to-Z index.
- National Cancer Institute (2024). Lymphedema and Cancer.
- National Center for Complementary and Integrative Health (2025). Detoxes and Cleanses: What You Need To Know.
- U.S. Food and Drug Administration (2026). Questions and Answers on Dietary Supplements.
One is cited for an absence. NCCIH’s Herbs at a Glance index lists fifty-six herbs and includes boswellia, ginger, horse chestnut and turmeric. Gotu kola and quercetin are not among them, and neither has a fact sheet at the NIH Office of Dietary Supplements under the names printed here. That is the finding, and it is flagged wherever either ingredient appears.
What these pieces will not do
- Recommend a product. Not this one, not a competitor, not a category. This site makes one recommendation — buy the single bottle — and it lives on the pricing page where it belongs.
- State an amount for a blend ingredient. None is published, so none is printed. Only conditional ceilings, with the condition attached every time.
- Describe a mechanism nobody published. None of the three claims on this product states a route, and these posts leave it unstated rather than borrowing a plausible-sounding one.
- Print a price. None was supplied with this product at all. The live figure is on the seller’s checkout screen and nowhere on this site.
- Print a timeline. No trial of this combination exists. A “most wait 4–8 weeks” line arrived with the seller pack; it is a marketing sentence, not a finding, and it appears nowhere here.
- Suggest that drops are an alternative to seeing somebody. They are not, and the posts say so in their closing sections rather than in a footer.
What they will do is show the working. Every figure in every post can be recomputed from something printed on the bottle, quoted from one of the ten sources, or derived by arithmetic the post sets out in full.
What this product does well, said once
It would be easy to read three posts about a 600 mg blend and conclude this is a careless product in every respect. A blog printing only the criticisms does the same selective job it complains about.
So, plainly. All six ingredients are named, where a great many blends name three and trail off. Four of the six have real NCCIH monographs — boswellia, curcumin, horse chestnut and ginger — which is a better hit rate than most products this desk has covered. Curcumin is named as the compound rather than as turmeric, which is the more precise word and the stronger disclosure. Quercetin is named as a phytosome, which identifies the preparation type. And the claim set is three structure-function sentences, all correctly asterisked, with the FDA disclaimer printed in full on the graphic carrying them — fewer and milder claims than most products in this series, which run to a dozen and promise the elimination of toxins.
None of that was compulsory, and it sharpens rather than softens the central problem: a product that names its ingredients carefully and then prints them only in an advertisement, with no panel, no plant parts, no standardisations and no amounts, has done the easy half of disclosure and stopped.
Product pages, if that is what you came for
The posts above are about reading labels in general. The product pages are about this one: what the bottle prints, what can and cannot be derived from it, and what the buying terms actually say. They carry the twelve findings this desk recorded.
| If you want | Read |
|---|---|
| What is in the bottle | Ingredients |
| The label, and why there is no panel | Label facts |
| Whether it suits you | Who it is for |
| The safety questions that cannot be checked | Safety |
| Packs and the return window | Pricing |
| The reading methods, as references | Guides |
Ask for the panel, and ask about the horse chestnut
A 2 fl oz bottle of liquid drops, two droppers a day, and no Supplement Facts panel on anything supplied with it. The only quantity that exists — 600 mg of blend a serving — is printed in a marketing graphic. No price was supplied either; the live figure and the 60-day return terms are on the seller’s checkout screen.
60-day window · Questions first? Call +1 (302) 200-3480